Global Inhaler Devices Market Research Report 2024
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Metered Dose Inhaler (MDI)
Dry Powder Inhaler (DPI)
Soft Mist Inhaler (SMI)
Segment by Application
Adults
Children
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
3M
Bespak
Gerresheimer AG
Hovione
Iconovo AB
Adherium
Cohero Health
Trudell Medical International
Beximco Pharmaceuticals Ltd
Boehringer Ingelheim GmbH
Cipla Ltd
GSK
PARI Medical Holding
Teva Pharmaceutical Industries Ltd

Table of Content
1 Inhaler Devices Market Overview
1.1 Product Overview and Scope of Inhaler Devices
1.2 Inhaler Devices Segment by Type
1.2.1 Global Inhaler Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Metered Dose Inhaler (MDI)
1.2.3 Dry Powder Inhaler (DPI)
1.2.4 Soft Mist Inhaler (SMI)
1.3 Inhaler Devices Segment by Application
1.3.1 Inhaler Devices Sales Comparison by Application: (2021-2027)
1.3.2 Adults
1.3.3 Children
1.4 Global Inhaler Devices Market Size Estimates and Forecasts
1.4.1 Global Inhaler Devices Revenue 2016-2027
1.4.2 Global Inhaler Devices Sales 2016-2027
1.4.3 Inhaler Devices Market Size by Region: 2016 Versus 2021 Versus 2027
2 Inhaler Devices Market Competition by Manufacturers
2.1 Global Inhaler Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global Inhaler Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Inhaler Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Inhaler Devices Manufacturing Sites, Area Served, Product Type
2.5 Inhaler Devices Market Competitive Situation and Trends
2.5.1 Inhaler Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Inhaler Devices Players Market Share by Revenue
2.5.3 Global Inhaler Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inhaler Devices Retrospective Market Scenario by Region
3.1 Global Inhaler Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Inhaler Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Inhaler Devices Market Facts & Figures by Country
3.3.1 North America Inhaler Devices Sales by Country
3.3.2 North America Inhaler Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Inhaler Devices Market Facts & Figures by Country
3.4.1 Europe Inhaler Devices Sales by Country
3.4.2 Europe Inhaler Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Inhaler Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Inhaler Devices Sales by Region
3.5.2 Asia Pacific Inhaler Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Inhaler Devices Market Facts & Figures by Country
3.6.1 Latin America Inhaler Devices Sales by Country
3.6.2 Latin America Inhaler Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Inhaler Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Inhaler Devices Sales by Country
3.7.2 Middle East and Africa Inhaler Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Inhaler Devices Historic Market Analysis by Type
4.1 Global Inhaler Devices Sales Market Share by Type (2016-2021)
4.2 Global Inhaler Devices Revenue Market Share by Type (2016-2021)
4.3 Global Inhaler Devices Price by Type (2016-2021)
5 Global Inhaler Devices Historic Market Analysis by Application
5.1 Global Inhaler Devices Sales Market Share by Application (2016-2021)
5.2 Global Inhaler Devices Revenue Market Share by Application (2016-2021)
5.3 Global Inhaler Devices Price by Application (2016-2021)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Corporation Information
6.1.2 3M Description and Business Overview
6.1.3 3M Inhaler Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 3M Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Bespak
6.2.1 Bespak Corporation Information
6.2.2 Bespak Description and Business Overview
6.2.3 Bespak Inhaler Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Bespak Product Portfolio
6.2.5 Bespak Recent Developments/Updates
6.3 Gerresheimer AG
6.3.1 Gerresheimer AG Corporation Information
6.3.2 Gerresheimer AG Description and Business Overview
6.3.3 Gerresheimer AG Inhaler Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Gerresheimer AG Product Portfolio
6.3.5 Gerresheimer AG Recent Developments/Updates
6.4 Hovione
6.4.1 Hovione Corporation Information
6.4.2 Hovione Description and Business Overview
6.4.3 Hovione Inhaler Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hovione Product Portfolio
6.4.5 Hovione Recent Developments/Updates
6.5 Iconovo AB
6.5.1 Iconovo AB Corporation Information
6.5.2 Iconovo AB Description and Business Overview
6.5.3 Iconovo AB Inhaler Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Iconovo AB Product Portfolio
6.5.5 Iconovo AB Recent Developments/Updates
6.6 Adherium
6.6.1 Adherium Corporation Information
6.6.2 Adherium Description and Business Overview
6.6.3 Adherium Inhaler Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Adherium Product Portfolio
6.6.5 Adherium Recent Developments/Updates
6.7 Cohero Health
6.6.1 Cohero Health Corporation Information
6.6.2 Cohero Health Description and Business Overview
6.6.3 Cohero Health Inhaler Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Cohero Health Product Portfolio
6.7.5 Cohero Health Recent Developments/Updates
6.8 Trudell Medical International
6.8.1 Trudell Medical International Corporation Information
6.8.2 Trudell Medical International Description and Business Overview
6.8.3 Trudell Medical International Inhaler Devices Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Trudell Medical International Product Portfolio
6.8.5 Trudell Medical International Recent Developments/Updates
6.9 Beximco Pharmaceuticals Ltd
6.9.1 Beximco Pharmaceuticals Ltd Corporation Information
6.9.2 Beximco Pharmaceuticals Ltd Description and Business Overview
6.9.3 Beximco Pharmaceuticals Ltd Inhaler Devices Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Beximco Pharmaceuticals Ltd Product Portfolio
6.9.5 Beximco Pharmaceuticals Ltd Recent Developments/Updates
6.10 Boehringer Ingelheim GmbH
6.10.1 Boehringer Ingelheim GmbH Corporation Information
6.10.2 Boehringer Ingelheim GmbH Description and Business Overview
6.10.3 Boehringer Ingelheim GmbH Inhaler Devices Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Boehringer Ingelheim GmbH Product Portfolio
6.10.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.11 Cipla Ltd
6.11.1 Cipla Ltd Corporation Information
6.11.2 Cipla Ltd Inhaler Devices Description and Business Overview
6.11.3 Cipla Ltd Inhaler Devices Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Cipla Ltd Product Portfolio
6.11.5 Cipla Ltd Recent Developments/Updates
6.12 GSK
6.12.1 GSK Corporation Information
6.12.2 GSK Inhaler Devices Description and Business Overview
6.12.3 GSK Inhaler Devices Sales, Revenue and Gross Margin (2016-2021)
6.12.4 GSK Product Portfolio
6.12.5 GSK Recent Developments/Updates
6.13 PARI Medical Holding
6.13.1 PARI Medical Holding Corporation Information
6.13.2 PARI Medical Holding Inhaler Devices Description and Business Overview
6.13.3 PARI Medical Holding Inhaler Devices Sales, Revenue and Gross Margin (2016-2021)
6.13.4 PARI Medical Holding Product Portfolio
6.13.5 PARI Medical Holding Recent Developments/Updates
6.14 Teva Pharmaceutical Industries Ltd
6.14.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.14.2 Teva Pharmaceutical Industries Ltd Inhaler Devices Description and Business Overview
6.14.3 Teva Pharmaceutical Industries Ltd Inhaler Devices Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Teva Pharmaceutical Industries Ltd Product Portfolio
6.14.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7 Inhaler Devices Manufacturing Cost Analysis
7.1 Inhaler Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Inhaler Devices
7.4 Inhaler Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Inhaler Devices Distributors List
8.3 Inhaler Devices Customers
9 Inhaler Devices Market Dynamics
9.1 Inhaler Devices Industry Trends
9.2 Inhaler Devices Growth Drivers
9.3 Inhaler Devices Market Challenges
9.4 Inhaler Devices Market Restraints
10 Global Market Forecast
10.1 Inhaler Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Inhaler Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Inhaler Devices by Type (2022-2027)
10.2 Inhaler Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Inhaler Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Inhaler Devices by Application (2022-2027)
10.3 Inhaler Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Inhaler Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Inhaler Devices by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer